Mind Medicine (MindMed) Inc.
MNMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -0.03 | 0.03 | -0.08 |
| FCF Yield | -16.14% | -44.91% | -73.86% | -8.09% |
| EV / EBITDA | -2.25 | -0.62 | 1.38 | -4.75 |
| Quality | ||||
| ROIC | -39.47% | -101.70% | -43.59% | -61.97% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.73 | 0.67 | 0.88 | 0.49 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -22.94% | -28.37% | -9.42% | -94.19% |
| Safety | ||||
| Net Debt / EBITDA | 2.38 | 0.92 | 2.65 | 1.46 |
| Interest Coverage | -45.52 | 0.00 | -44.37 | -268.42 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,392.13 | -477.43 | -239.07 | -582.94 |